Agenda
Thursday, March 1
| 7:30-9:00 | Arrival & Registration Continental Breakfast |
| 9:00-9:05 | Welcome and Program Overview |
| 9:05-9:15 | Brian Kennedy – Buck Institute for Research on Aging Introduction to Buck Institute for Research on Aging |
| Session One | Chair: Thomas A. Rando, MD, PhD – Stanford University School of Medicine |
| 9:15-9:45 | George Q. Daley, MD, PhD – HHMI/Children’s Hospital Boston Lin28 in Disease and Development |
| 9:45-10:15 | Lisa M. Ellerby, PhD – Buck Institute for Research on Aging Designing Stem Cells in Huntington Disease |
| 10:15-10:45 | Paul Robson, PhD - Genome Institute of Singapore The Potency of Human Embryonic Stem Cells |
| 10:45-11:00 | Break |
| 11:00-11:30 | Arturo Alvarez-Buylla, PhD – UCSF School of Medicine Neural Stem Cells in the Adult Brain |
| 11:30-12:00 | Rachelle J. Sells Galvin, PhD – Eli Lilly and Company Application of Stem Cell Technologies to Drug Development |
| 12:00-12:30 | Anne Brunet, PhD – Stanford University Neural Stem Cell Aging |
| 12:30-1:30 | Buffet Lunch |
| Session Two | Chair: Victoria V. Lunyak, PhD – Buck Institute for Research on Aging |
| 1:30-2:00 | Michael Geoffrey Rosenfeld, MD – UCSD ncRNAs in Developmental and Regulated Gene Transcriptional Programs |
| 2:00-2:30 | Arvind Ramanathan, PhD – Buck Institute for Research on Aging Stem Cell Metabolism: Using Metabolomics to Study the Role of Aryl Hydrocarbon Receptors |
| 2:30-3:00 | Juan Carlos Izpisύa Belmonte, PhD – The Salk Institute for Biological Studies Generation and Correction of Laminopathy-Associated LMNA Mutations in Patient Specific iPSCs |
| 3:00-3:15 | Break |
| 3:15-3:45 | Deepak Lamba, MBBS, MS, PhD – Buck Institute for Research on Aging Human Pluripotent Stem Cells: Applications for Retinal Diseases |
| 3:45-4:15 | John Crispino, PhD – Northwestern University Aberrant Hematopoiesis in Down Syndrome |
| 4:15-4:45 | Susan J. Fisher, PhD – UCSF Specifying a Human Embryonic or a Trophoblast Fate |
| 4:45-6:00 | Wine and Poster Session |
| 6:00-7:30 | Dinner at the Buck Institute |
| Keynote | Chair: Julie Andersen, PhD – Buck Institute for Research on Aging |
| 7:30-8:20 | Keynote Address Ole Isacson, MD – McLean Hospital/Harvard Medical School New Medicines and Treatments for Parkinson's Disease Patients From Stem and iPS Cells |
Friday, March 2
| 8:30-9:00 | Registration Continental Breakfast |
| Session Three | Chair: Lisa M. Ellerby, PhD – Buck Institute for Research on Aging |
| 9:05-9:35 | Thomas A. Rando, MD, PhD – Stanford University School of Medicine Epigenetic Mechanisms of Stem Cell Aging and Rejuvenation |
| 9:35-10:15 | TBA |
| 10:15-10:35 | Jing-Dong Jackie Han, PhD – Chinese Academy of Science In Search for the Regulatory Network of Aging |
| 10:35-11:05 | Victoria V. Lunyak, PhD – Buck Institute for Research on Aging Epigenetic Regulations in Human Mesenchymal Stem Cell Aging |
| 11:05-11:15 | Break |
| 11:15-11:45 | Leanne Jones, PhD – UCSD Maintenance of Niche Function and Tissue Homeostasis During Aging |
| 11:45-12:15 | Heinrich Jasper, PhD – University of Rochester Control of Proliferative Plasticity in the Adult Intestine of Drosophila |
| 12:15-12:45 | Irina Conboy, PhD – UC Berkeley Slowing Down the Rate of Aging Through Stem Cell Engineering |
| 12:45-1:30 | Buffet Lunch |
| Session Four |
CIRM and NIH Roadmap to Parkinson Disease Study |
| 1:30-2:00 | Ellen Feigal, MD – CIRM CIRM Overview |
| 2:00-2:30 | Arnold R. Kriegstein MD, PhD – UCSF School of Medicine Neural Stem and Progenitor Cells in Human Cortical Development and Evolution |
| 2:30-3:00 | Johannes Schwarz, MD – Technical University of Munich Fetal Human Neural Progenitor Cells as a Model to Study Brain Development in Vitro |
| 3:00-3:30 | Kwang-Soo Kim, PhD – McLean Hospital/Harvard Medical School Protein-Based iPS Cells for Regenerative Medicine |
| 3:30-3:45 | Break |
| 3:45-4:15 | Xianmin Zeng, PhD – Buck Institute for Research on Aging Parkinson's Disease: ESC/iPSC-derived Dopaminergic Neurons for Therapy and Screening |
| 4:15-4:45 | Russell Lonser, MD – NIH Clinical Center, NINDS Clinical Trial at the NIH Clinical Center for Neurological Disorders |
| 4:45-5:15 | Joel M. Gottesfeld, PhD – The Scripps Research Institute Modeling Neurodegenerative Diseases with iPSC-derived Neurons and Screens for Small Molecule Therapeutics |
| 5:15-5:45 | Mahendra Rao, MD, PhD - NIH Stem Cells for Screening and Therapy - NIH CRM Efforts |
